CTMX
Price
$0.64
Change
+$0.01 (+1.59%)
Updated
Apr 17, 02:30 PM (EDT)
Capitalization
50.44M
20 days until earnings call
TECH
Price
$48.24
Change
-$1.73 (-3.46%)
Updated
Apr 17, 04:53 PM (EDT)
Capitalization
7.9B
13 days until earnings call
Ad is loading...

CTMX vs TECH

Header iconCTMX vs TECH Comparison
Open Charts CTMX vs TECHBanner chart's image
CytomX Therapeutics
Price$0.64
Change+$0.01 (+1.59%)
Volume$100
Capitalization50.44M
Bio-Techne
Price$48.24
Change-$1.73 (-3.46%)
Volume$2.61K
Capitalization7.9B
CTMX vs TECH Comparison Chart
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. TECH commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a Hold and TECH is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 17, 2025
Stock price -- (CTMX: $0.63 vs. TECH: $49.97)
Brand notoriety: CTMX and TECH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 27% vs. TECH: 79%
Market capitalization -- CTMX: $50.44M vs. TECH: $7.9B
CTMX [@Biotechnology] is valued at $50.44M. TECH’s [@Biotechnology] market capitalization is $7.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $287.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 0 FA rating(s) are green whileTECH’s FA Score has 1 green FA rating(s).

  • CTMX’s FA Score: 0 green, 5 red.
  • TECH’s FA Score: 1 green, 4 red.
According to our system of comparison, TECH is a better buy in the long-term than CTMX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 5 TA indicator(s) are bullish while TECH’s TA Score has 4 bullish TA indicator(s).

  • CTMX’s TA Score: 5 bullish, 3 bearish.
  • TECH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CTMX is a better buy in the short-term than TECH.

Price Growth

CTMX (@Biotechnology) experienced а +25.86% price change this week, while TECH (@Biotechnology) price change was -7.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.38%. For the same industry, the average monthly price growth was -14.15%, and the average quarterly price growth was -25.17%.

Reported Earning Dates

CTMX is expected to report earnings on Aug 07, 2025.

TECH is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+6.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($7.9B) has a higher market cap than CTMX($50.4M). TECH has higher P/E ratio than CTMX: TECH (50.99) vs CTMX (1.66). TECH YTD gains are higher at: -30.536 vs. CTMX (-38.864). TECH has higher annual earnings (EBITDA): 307M vs. CTMX (26.8M). TECH has more cash in the bank: 178M vs. CTMX (101M). CTMX has less debt than TECH: CTMX (9.39M) vs TECH (395M). TECH has higher revenues than CTMX: TECH (1.2B) vs CTMX (138M).
CTMXTECHCTMX / TECH
Capitalization50.4M7.9B1%
EBITDA26.8M307M9%
Gain YTD-38.864-30.536127%
P/E Ratio1.6650.993%
Revenue138M1.2B12%
Total Cash101M178M57%
Total Debt9.39M395M2%
FUNDAMENTALS RATINGS
CTMX vs TECH: Fundamental Ratings
CTMX
TECH
OUTLOOK RATING
1..100
410
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
3
Undervalued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
9677
PRICE GROWTH RATING
1..100
8665
P/E GROWTH RATING
1..100
9934
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is somewhat better than the same rating for CTMX (53). This means that TECH’s stock grew somewhat faster than CTMX’s over the last 12 months.

TECH's Profit vs Risk Rating (87) in the Biotechnology industry is in the same range as CTMX (100). This means that TECH’s stock grew similarly to CTMX’s over the last 12 months.

TECH's SMR Rating (77) in the Biotechnology industry is in the same range as CTMX (96). This means that TECH’s stock grew similarly to CTMX’s over the last 12 months.

TECH's Price Growth Rating (65) in the Biotechnology industry is in the same range as CTMX (86). This means that TECH’s stock grew similarly to CTMX’s over the last 12 months.

TECH's P/E Growth Rating (34) in the Biotechnology industry is somewhat better than the same rating for CTMX (99). This means that TECH’s stock grew somewhat faster than CTMX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTMXTECH
RSI
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 2 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FAAR26.360.22
+0.84%
First Trust Alt Abs Ret Strat ETF
DFIC27.53-0.01
-0.04%
Dimensional International Core Eq 2 ETF
MRSK31.33-0.19
-0.62%
Toews Agility Managed Risk ETF
ECC7.29-0.10
-1.35%
Eagle Point Credit Company
SEPZ35.37-0.57
-1.58%
TrueShares Structured Outcome Sep ETF

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with MLEC. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then MLEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
-0.29%
MLEC - CTMX
42%
Loosely correlated
-1.22%
PYXS - CTMX
39%
Loosely correlated
+2.07%
TECH - CTMX
39%
Loosely correlated
-2.14%
BCAB - CTMX
38%
Loosely correlated
-0.94%
XNCR - CTMX
38%
Loosely correlated
-0.21%
More